Hydroxychloroquine as adjunctive therapy in steroid-dependent pediatric Kikuchi-Fujimoto disease with liver dysfunction: A case report

Kikuchi–Fujimoto disease is usually self-limiting, but treatment of steroid-dependent disease in children remains uncertain. We report a 7-year-old girl with biopsy-confirmed Kikuchi–Fujimoto disease and severe liver dysfunction. She presented with intermittent fever and cervical lymphadenopathy, followed by rash and worsening liver dysfunction. Cervical lymph node biopsy revealed necrotizing lymphadenitis without evidence of malignancy. Antinuclear and U1 ribonucleoprotein antibodies were positive; liver–kidney microsomal type 1 antibodies were subsequently detected. Serologic tests for the viruses examined were negative, although hepatitis A testing was not performed. Retrospective assessment using the revised International Autoimmune Hepatitis Group scoring system did not reach the threshold for probable autoimmune hepatitis. Nevertheless, autoimmune hepatitis could not be excluded because liver histology was unavailable and the viral evaluation was incomplete. After relapse during prednisolone tapering, she received methylprednisolone pulse therapy followed by prednisolone and hydroxychloroquine. Remission was achieved, allowing gradual corticosteroid tapering. Prednisolone was discontinued at month 39 and hydroxychloroquine at month 50 after disease onset. No relapse occurred during the subsequent 8-month follow-up. No hydroxychloroquine-related adverse events, including retinopathy, were observed during 44 months of treatment or the subsequent follow-up. This case adds to the limited experience with prolonged hydroxychloroquine use in younger children with steroid-dependent Kikuchi–Fujimoto disease. Hydroxychloroquine may have contributed to corticosteroid tapering, although its independent efficacy cannot be established because it was initiated alongside intensified corticosteroid therapy.

Authors

Institutions

Publication Details

Journal
Modern Rheumatology Case Reports
Published
2026-11-19
DOI
https://doi.org/10.1093/mrcr/rxag103
Primary Topic
Lymphadenopathy Diagnosis and Analysis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Hydroxychloroquine as adjunctive therapy in steroid-dependent pediatric Kikuchi-Fujimoto disease with liver dysfunction: A case report

Shunichiro Takezaki, M. Ueki, Takiko Nobuta, Masataka Hasegawa et al.
Modern Rheumatology Case Reports
Lymphadenopathy Diagnosis and Analysis
article

Hydroxychloroquine as adjunctive therapy in steroid-dependent pediatric Kikuchi-Fujimoto disease with liver dysfunction: A case report

Shunichiro Takezaki, M. Ueki, Takiko Nobuta, Masataka Hasegawa, Katsushige Yamashiro, Tadashi Ariga, Ryota Suzuki, Atsushi Manabe, Masafumi Yamada, Satoru Ono, Itaru Hayasaka, Ryosuke Yokokawa, Hiroki Ohata, Naoya Kaneko, Yuto Suzuki
article en

Abstract

Kikuchi–Fujimoto disease is usually self-limiting, but treatment of steroid-dependent disease in children remains uncertain. We report a 7-year-old girl with biopsy-confirmed Kikuchi–Fujimoto disease and severe liver dysfunction. She presented with intermittent fever and cervical lymphadenopathy, followed by rash and worsening liver dysfunction. Cervical lymph node biopsy revealed necrotizing lymphadenitis without evidence of malignancy. Antinuclear and U1 ribonucleoprotein antibodies were positive; liver–kidney microsomal type 1 antibodies were subsequently detected. Serologic tests for the viruses examined were negative, although hepatitis A testing was not performed. Retrospective assessment using the revised International Autoimmune Hepatitis Group scoring system did not reach the threshold for probable autoimmune hepatitis. Nevertheless, autoimmune hepatitis could not be excluded because liver histology was unavailable and the viral evaluation was incomplete. After relapse during prednisolone tapering, she received methylprednisolone pulse therapy followed by prednisolone and hydroxychloroquine. Remission was achieved, allowing gradual corticosteroid tapering. Prednisolone was discontinued at month 39 and hydroxychloroquine at month 50 after disease onset. No relapse occurred during the subsequent 8-month follow-up. No hydroxychloroquine-related adverse events, including retinopathy, were observed during 44 months of treatment or the subsequent follow-up. This case adds to the limited experience with prolonged hydroxychloroquine use in younger children with steroid-dependent Kikuchi–Fujimoto disease. Hydroxychloroquine may have contributed to corticosteroid tapering, although its independent efficacy cannot be established because it was initiated alongside intensified corticosteroid therapy.

Modern Rheumatology Case Reports
Hokkaido University (JP), Shizuoka City Shimizu Hospital (JP), Shimada Municipal Hospital (JP), Hokkaido University Hospital (JP), Nikko Memorial Hospital (JP), KKR Sapporo Medical Center (JP), Rakuno Gakuen University (JP)
Lymphadenopathy Diagnosis and Analysis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon